Osaic Holdings’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-5,808
| Closed | -$32K | – | 8129 |
|
|
2025
Q3 | $32K | Sell |
5,808
-20
| -0.3% | -$102 | ﹤0.01% | 5608 |
|
|
2025
Q2 | $22.2K | Buy |
5,828
+200
| +4% | +$621 | ﹤0.01% | 5622 |
|
|
2025
Q1 | $14.8K | Hold |
5,628
| – | – | ﹤0.01% | 5562 |
|
|
2024
Q4 | $19.9K | Hold |
5,628
| – | – | ﹤0.01% | 5347 |
|
|
2024
Q3 | $25.7K | Hold |
5,628
| – | – | ﹤0.01% | 5216 |
|
|
2024
Q2 | $24.5K | Hold |
5,628
| – | – | ﹤0.01% | 5201 |
|
|
2024
Q1 | $28.3K | Buy |
5,628
+319
| +6% | +$1.79K | ﹤0.01% | 5138 |
|
|
2023
Q4 | $33.3K | Sell |
5,309
-54,372
| -91% | -$311K | ﹤0.01% | 5168 |
|
|
2023
Q3 | $425K | Sell |
59,681
-26,319
| -31% | -$207K | ﹤0.01% | 3390 |
|
|
2023
Q2 | $876K | Buy |
86,000
+48,191
| +127% | +$503K | ﹤0.01% | 2645 |
|
|
2023
Q1 | $343K | Buy |
37,809
+33,819
| +848% | +$248K | ﹤0.01% | 3430 |
|
|
2022
Q4 | $29K | Sell |
3,990
-936
| -19% | -$5.72K | ﹤0.01% | 5316 |
|
|
2022
Q3 | $32K | Buy |
4,926
+2,263
| +85% | +$12.1K | ﹤0.01% | 5254 |
|
|
2022
Q2 | $13K | Sell |
2,663
-974
| -27% | -$4.82K | ﹤0.01% | 5914 |
|
|
2022
Q1 | $21K | Sell |
3,637
-270
| -7% | -$1.33K | ﹤0.01% | 5664 |
|
|
2021
Q4 | $20K | Buy |
3,907
+50
| +1% | +$275 | ﹤0.01% | 5796 |
|
|
2021
Q3 | $25K | Buy |
3,857
+3,500
| +980% | +$20.9K | ﹤0.01% | 5621 |
|
|
2021
Q2 | $2K | Hold |
357
| – | – | ﹤0.01% | 6742 |
|
|
2021
Q1 | $2K | Hold |
357
| – | – | ﹤0.01% | 6517 |
|
|
2020
Q4 | $2K | Hold |
357
| – | – | ﹤0.01% | 6098 |
|
|
2020
Q3 | $3K | Hold |
357
| – | – | ﹤0.01% | 5753 |
|
|
2020
Q2 | $3K | Hold |
357
| – | – | ﹤0.01% | 5689 |
|
|
2020
Q1 | $3K | Buy |
+357
| New | +$2.59K | ﹤0.01% | 5571 |
|
Osaic Holdings's SCPH Position: Q4 2025 in Review
Osaic Holdings sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 5,808 shares — an estimated $32K sold.
Osaic Holdings first reported a position in SCPH in Q1 2020 and held it in 23 quarters. The position peaked at $876K in Q2 2023. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- Osaic Holdings reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Osaic Holdings sold 5,808 scPharmaceuticals shares in Q4 2025, an estimated $32K.
- Osaic Holdings first reported a position in scPharmaceuticals in Q1 2020 and held it in 23 quarters.
- Osaic Holdings's scPharmaceuticals position peaked at $876K in Q2 2023.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.